Mrp2 Knockout Rat
Model Detail >
Nomenclature:
SD-
Abcc2
tm1sage
Genotype:
Homozygous
Product number:
TGRS4340
Research Applications
- DMPK
- PK/PD
- Formulation
- Efflux assays
- Efficacy
- Drug-drug interactions
- Tissue distribution
- Dubin-Johnson syndrome
Downloads
File size: 283.82kFile size: 26.63k
Description
Homozygous Mrp2 null rats display compromised biliary excretion and hyperbilirubinemia. This results in accumulation of glutathione-conjugated drugs in the liver.
Request a quote and a SAGE® Labs research specialist will contact you with an estimated price and delivery date.
Characteristics
- Biallelic 726 bp deletion within Abcc2 gene
- Homozygous knockouts display total loss of protein via Western blot
- Decreased transport of endogenous glutathione
- Hyperbilirubinemia
- Background Strain: Sprague-Dawley
Table 1. Glutathione level of Mrp2 (-/-) and wild type rats (nM/g)
Table 2. Serum chemistry for Mrp2 (-/-) and wild type rats
Additional Information
Mrp2 is expressed in the liver and functions in biliary transport. The gene’s substrates include anticancer compounds such as vinblastine, enabling it to confer multiple drug resistance to tumor cells. This model is useful for forumational, efficacy, tissue distribution, and DMPK assays.
Publications
- Zamek-Gliszczynski, M, et al. Minor compensatory changes in SAGE Mdr1a (P-gp), Bcrp, and Mrp2 knockout rats do not detract from their utility in the study of transporter-mediated pharmacokinetics.
- Zamek-Gliszczynski, M, et al. Characterization of SAGE Labs Mdr1a (P-gp), Bcrp, and Mrp2 knockout rats using loperamide, paclitaxel, sulfasalazine, and carboxydichlorofluorescein pharmacokinetics. DMD. 2012
